About Us

About Us

Our mission is to serve our clients’ needs through timely, thorough, creative and innovative representation. Our clients and their employees are customers we appreciate and they deserve a salute, a smile and service that “wows” them.

Contact me, Bill Broydrick today at 202-679-1004, or billb@broydrick.com.

What’s the buzz …

Payments to Cranberry Growers

When the USDA announced a measure to assist farmers negatively impacted by retaliatory tariffs on US agriculture, Broydrick & Associates worked to ensure the Cranberry Growers Coalition was included in the commodities. The USDA authorized $16 billion in relief programs through the Market Facilitation Program, Food Purchase and Distribution Program, and the Agricultural Trade Promotion Program.

The tariffs ranged from 10% on juice cocktails from Canada up to 55% on frozen cranberry imports to China—posing a significant threat to the health of the Cranberry industry. Because of the advocacy work on behalf of Cranberry Growers, the producers were found to be eligible through the Market Facilitation Program. The inclusion ensured that direct payments would go to growers to help the industry survive despite the retaliatory tariffs.

Blueberries Included in the USDA’s Coronavirus Food Assistance Program

The USDA launched the Coronavirus Food Assistance Program (CFAP) to assist US farmers impacted by the COVID-19 pandemic. This program offers direct relief to producers facing additional marketing and operational costs to stay afloat during the pandemic. Because of the extra precautions and logistics required to ensure the safety of workers and continuation of the food chain, many in the agricultural industry were facing significant market chain disruptions and costs, including blueberry growers.

The Munger Farms, a long-time client of Broydrick & Associates, sought our assistance to request the addition of blueberries in the CFAP. Initially blueberries were not listed as an eligible specialty crop, but to qualify for CFAP payments, the fruit—representing a significant portion of Munger Farm’s business—must be included in the specialty crop list. Broydrick & Associates got to work and on July 9, 2020, the USDA announced they would include an additional 40 specialty crops in the list, including blueberries.

Resolution of Dispute with Customs & Border Protection on the Import of Gloves in Malaysia

During the COVID-19 crisis, the U.S. Customs and Border Protection stopped the import of surgical gloves from many of the predominant manufacturers in Malaysia. This detention order included gloves that were in transit to a logistics manufacturing client of Broydrick & Associates.

Broydrick & Associates worked with the Customs and Boarder Protection contacts, as well as our contacts in the Malaysian rubber industry to resolve the dispute as it pertained to our client and release the PPE. This work ensured that the protective gloves could be used by our client’s employees as well as distributed to their customer base, as needed during the pandemic.

California’s Board of Pharmacy Allows Pharmaceutical Shipments for COVID-19 Patients

During the COVID-19 crisis, logistical hurdles were faced by patients in California who required certain regulated medications. Due to shipping regulations in place from the California Board of Pharmacy, some medications were blocked and inaccessible, including critical medications manufactured by a Broydrick & Associates’ pharmaceutical client.

Broydrick & Associates worked with the California Board of Pharmacy to ensure they issued a temporary order to allow for the shipments during this unprecedented circumstance. Our work helped to ensure highly compromised COVID-19 patients and other patients could receive the critical drugs they needed.

Work with the IRS for a 48-Hour Turnaround on a Permit (Instead of 30 Days)

A long-term client of Broydrick & Associates contacted us for emergency assistance with a permit issuance from the IRS. A name discrepancy on the IRS website had blocked the issuance of a crucial permit the client required. The normal turnaround time for a permit is 30 days, but in this case, our client needed an immediate issuance.

Bill Broydrick got to work, cutting through red tape at the IRS and reaching out to contacts to resolve the discrepancy and secure the issuance of the permit. Within 48-hours, we were able to secure the needed permit for our client, so they could move forward with their business.

Securing & Increasing Funding for the Establishment of the Cranberry Research Station

Wisconsin is a world leader in cranberry production, with 250 growers who produce two-thirds of the cranberry crop in the United States (550 million pounds per year). Since the cranberry industry is highly impacted by weather and the economy, the research station allows researchers, growers, and USDA experts to monitor and develop a resilient crop.

Broydrick & Associates has worked with the Wisconsin State Cranberry Growers for decades, including on this project. The research station required grant work to secure multiple funding assistance increases for the growers. Broydrick delivered with the assistance, helping the Wisconsin Cranberry State Growers establish a new research station in Black River Falls. This station will provide data to keep the industry healthy for years to come.

Moore Asks Pelosi to Help Clean Water Agencies

Read letter here.

FY2020 Appropriation Successes

Today, the House and Senate have passed two appropriations bills for FY2020 which are now heading to the President’s desk for signature. The government funding expires on Friday, December 20th, 2019 at midnight.

Broydrick and Associates has worked diligently for our clients on many diverse appropriation requests and have been very successful in getting what our clients needed. Read More.

Premier’s ProvideGx to launch intravenous nutrition drug

Premier subsidiary ProvideGx is now supplying cysteine hydrochloride injections to its member providers, the generic-drug division of the group purchasing and consulting organization announced Tuesday.

ProvideGx teamed up with the manufacturer Exela Pharma Sciences to deliver the only Food and Drug Administration-approved version of the drug. The injection used for pediatric and adult patients who need intravenous nutrition has been in short supply since 2015. Read more at link to Modern Healthcare.


U.S. Secretary of Agriculture Sonny Perdue has announced USDA will take action to assist farmers who have been negatively impacted by unjustified retaliatory tariffs on U.S. agricultural goods and other trade disruptions. Specifically, the USDA is authorized to provide up to $16 billion in relief programs including the Market Facilitation Program (MFP), Food Purchase and Distribution Program (FPDP) and the Agricultural Trade Promotion (ATP) Program. Read more.


On May 17, 2019, the cranberry industry finally received some good news amidst the ongoing trade war. The White House announced it reached a trade agreement with Mexico and Canada—the U.S. will suspend Section 232 Steel and Aluminum tariffs and in response, Mexico and Canada will suspend their retaliatory tariffs. Read more.


Rural Development Lending Reform Update

Broydrick & Associates continues its work towards reforming and enhancing RD lending to create robust markets for lenders and borrowers alike. Today, we brought our FY2020 RD lending initiatives to Puerto Rico at the National Rural Lenders’ Roundtable! Read more.

Retaliatory Tariffs on Cranberry Industry

Due to President Trump’s decision to impose tariffs on steel and aluminum imports, retaliatory tariffs have been imposed on many U.S. goods. Canada, Mexico, China, and the European Union are among those who have instituted retaliatory tariffs on U.S. imports such as cranberries and cranberry products. President Trump claims that the specific measures are meant to protect U.S. national security interests. Read more

Exact Sciences CEO Says Company Has “Attractive Long-Term Opportunity.”

Barron’s (5/2, Bary, 948K) reports that according to Exact Sciences CEO Kevin Conroy, there continues to be “big growth from the company’s colon-cancer test,” Cologuard. According to Barron’s, Exact Sciences “has successfully secured reimbursement from Medicare and most commercial insurers for the self-administered test.” Conroy says that Cologuard “could ultimately deliver revenue of $5 to $6 billion annually, more than 10 times projected 2018 sales, as physicians and U.S. consumers embrace it.” He said, “We have an attractive long-term opportunity given the size of the market and our position in it,” adding, “We’re still in the early innings.”

Exela CEO Dr. Phanesh Koneru Interviews President George W. Bush at Becker’s Healthcare Conference

We’re proud to welcome our newest clients:

Read more on Bill’s Blog